Johnson Pharmacare Statistics
Total Valuation
BOM:532154 has a market cap or net worth of INR 484.00 million. The enterprise value is 489.91 million.
Market Cap | 484.00M |
Enterprise Value | 489.91M |
Important Dates
The last earnings date was Friday, May 23, 2025.
Earnings Date | May 23, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BOM:532154 has 550.00 million shares outstanding. The number of shares has increased by 6.15% in one year.
Current Share Class | 550.00M |
Shares Outstanding | 550.00M |
Shares Change (YoY) | +6.15% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 2.17% |
Owned by Institutions (%) | n/a |
Float | 507.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | -145.17 |
PB Ratio | 0.86 |
P/TBV Ratio | 0.86 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -83.92 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.58, with a Debt / Equity ratio of 0.01.
Current Ratio | 13.58 |
Quick Ratio | 0.01 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1.03% and return on invested capital (ROIC) is -0.45%.
Return on Equity (ROE) | -1.03% |
Return on Assets (ROA) | -0.44% |
Return on Invested Capital (ROIC) | -0.45% |
Return on Capital Employed (ROCE) | -0.73% |
Revenue Per Employee | -833,500 |
Profits Per Employee | -1.46M |
Employee Count | 4 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.10% in the last 52 weeks. The beta is -0.38, so BOM:532154's price volatility has been lower than the market average.
Beta (5Y) | -0.38 |
52-Week Price Change | -1.10% |
50-Day Moving Average | 0.93 |
200-Day Moving Average | 1.06 |
Relative Strength Index (RSI) | 38.73 |
Average Volume (20 Days) | 1,035,187 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532154 had revenue of INR -3.33 million and -5.84 million in losses. Loss per share was -0.01.
Revenue | -3.33M |
Gross Profit | -3.33M |
Operating Income | -4.12M |
Pretax Income | -5.84M |
Net Income | -5.84M |
EBITDA | n/a |
EBIT | -4.12M |
Loss Per Share | -0.01 |
Balance Sheet
The company has 144,000 in cash and 6.05 million in debt, giving a net cash position of -5.91 million or -0.01 per share.
Cash & Cash Equivalents | 144,000 |
Total Debt | 6.05M |
Net Cash | -5.91M |
Net Cash Per Share | -0.01 |
Equity (Book Value) | 561.69M |
Book Value Per Share | 1.09 |
Working Capital | 144.83M |
Cash Flow
Operating Cash Flow | -19.09M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | 123.64% |
Pretax Margin | 175.10% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
BOM:532154 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.15% |
Shareholder Yield | n/a |
Earnings Yield | -1.21% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on April 7, 2022. It was a forward split with a ratio of 1.1.
Last Split Date | Apr 7, 2022 |
Split Type | Forward |
Split Ratio | 1.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |